Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
AstraZeneca
Merck
Moodys
McKinsey

Last Updated: January 23, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for haemophilus b conjugate vaccine (tetanus toxoid conjugate)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00707148 ↗ Pertussis Vaccine in Healthy Pregnant Women Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 2009-01-01 The purpose of this study is to look at the safety and immunogenicity of a combination vaccine that includes tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). The study will be conducted in 48 pregnant women and 32 non-pregnant women. Safety of the newborn infant and the effect of the mother's vaccination on the infants' immune responses prior to vaccinating infants with another combination vaccine to protect against diphtheria, tetanus, and pertussis will be evaluated. Participants will be 18-45 years old. Pregnant volunteers will be 30-32 weeks pregnant and at a low risk for pregnancy complications. Pregnant volunteers will receive 2 injections (1 vaccine and 1 placebo, inactive substance); non-pregnant volunteers will receive 1 injection of vaccine. Blood samples will be collected from the mother and infant, along with the baby's growth measurements. Participation for mother infant pairs is about 15 months and about 7 months for non-pregnant women.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for haemophilus b conjugate vaccine (tetanus toxoid conjugate)

Condition Name

Condition Name for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Intervention Trials
Diphtheria 1
Pertussis 1
Tetanus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Intervention Trials
Whooping Cough 1
Tetanus 1
Diphtheria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for haemophilus b conjugate vaccine (tetanus toxoid conjugate)

Trials by Country

Trials by Country for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Location Trials
Washington 1
Texas 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for haemophilus b conjugate vaccine (tetanus toxoid conjugate)

Clinical Trial Phase

Clinical Trial Phase for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for haemophilus b conjugate vaccine (tetanus toxoid conjugate)

Sponsor Name

Sponsor Name for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Sponsor Trials
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
AstraZeneca
Colorcon
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.